Patient attitudes towards faecal immunochemical testing for haemoglobin as an alternative to colonoscopic surveillance of groups at increased risk of colorectal cancer

Journal of Medical Screening

Volumn 20, Issue 3, 2013, Pages 149-156

  Bowyer, Harriet L ^a   Vart, Gemma ^a   Kralj Hans, Ines ^b   Atkin, Wendy ^b   Halloran, Stephen P ^c   Seaman, Helen ^d   Wardle, Jane ^a   Von Wagner, Christian ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Bowel cancer; Cancer surveillance; Colonoscopy; Faecal immunochemical test; Patient preference

Indexed keywords

AGED; ARTICLE; ATTITUDE TO HEALTH; BLOOD; CANCER EPIDEMIOLOGY; COLONOSCOPY; COLORECTAL TUMOR; FAECAL IMMUNOCHEMICAL TEST; FEMALE; HUMAN; IMMUNOCHEMISTRY; INTESTINE CANCER; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; OCCULT BLOOD; PATIENT ATTITUDE; PATIENT PREFERENCE; PSYCHOLOGICAL ASPECT; RISK FACTOR; UNITED KINGDOM;

BOWEL CANCER; CANCER SURVEILLANCE; COLONOSCOPY; FAECAL IMMUNOCHEMICAL TEST; PATIENT PREFERENCE;

AGED; ATTITUDE TO HEALTH; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOCHEMISTRY; LONDON; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT PREFERENCE; RISK FACTORS;

EID: 84898493847     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141313503953     Document Type: Article

References (33)

1. Logan RF, Patnick J, Nickerson C, Coleman L, Rutter MD, von Wagner C. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut 2012;61:1439-46.
2. Atkin WS, Saunders BP. Surveillance guidelines after removal of colorectal adenomatous polyps. Gut 2002;51:V6-V9.
3. Marshall D, McGregor SE, Currie G. Measuring Preferences for Colorectal Cancer Screening What are the Implications for Moving Forward? Patient 2010;3:79-89.
4. Inadomi JM, Vijan S, Janz NK, Fagerlin A, Thomas JP, Lin YV, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med 2012;172:575-82.
5. Marshall DA, Johnson FR, Phillips KA, Marshall JK, Thabane L, Kulin NA. Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health 2007;10:415-30.
6. Dolan JG, Boohaker E, Allison J, Imperiale TF. Patients' preferences and priorities regarding colorectal cancer screening. Med Decis Making 2013;33:59-70.
7. Schroy PC, Glick JT, Robinson PA, Heeren T. Screening preferences of patients at familial risk of colorectal cancer. Dig Dis Sci 2007;52:2788-95.
8. Wolf RL, Basch CE, Brouse CH, Shmukler C, Shea S. Patient preferences and adherence to colorectal cancer screening in an urban population. Am J Public Health 2006;96:809-11.
9. Lund JN, Scholefield JH, Grainge MJ, Smith SJ, Mangham C, Armitage NC, et al. Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial. Gut 2001;49:91-6.
10. Steele RJ, McClements PL, Libby G, Black R, Morton C, Birrell J, et al. Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut 2009;58:530-5.
11. McLachlan SA, Clements A, Austoker J. Patients' experiences and reported barriers to colonoscopy in the screening context-A systematic review of the literature. Patient Educ Couns 2012;86:137-46.
12. Burch JA, Soares-Weiser K, St John DJB, Duffy S, Smith S, Kleijnen J, et al. Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. J Med Screen 2007;14:132-7.
13. van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90.
14. Smith A, Young GP, Cole SR, Bampton P. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 2006;107:2152-9.
15. Park DI, Ryu S, Kim YH, Lee SH, Lee CK, Eun CS, et al. Comparison of Guaiac-Based and Quantitative Immunochemical Fecal Occult Blood Testing in a Population at Average Risk Undergoing Colorectal Cancer Screening. Am J Gastroenterol 2010;105:2017-25.
16. Vart G, Banzi R, Minozzi S. Comparing participation rates between immunochemical and guaiac faecal occult blood tests: A systematic review and meta-analysis. Prev Med 2012;55:87-92.
17. Weller DP, Patnick J, McIntosh HM, Dietrich AJ. Uptake in cancer screening programmes. Lancet Oncol 2009;10:693-9.
18. Janda M, Hughes K, Tong S, Stanton WR, Aitken J, Clavarino A, et al. Faecal occult blood test: current practice in a rural Queensland community. Aust J Rural Health 2002;10:57-64.
19. Lane JM, Chow E, Young GP, Good N, Smith A, Bull J, et al. Interval Fecal Immunochemical Testing in a Colonoscopic Surveillance Program Speeds Detection of Colorectal Neoplasia. Gastroenterology 2010;139:1918-26.
20. Chow E, Lane JM, Smith A, Cole SR, Bampton PA, Morcom J, et al. Interval fecal occult blood testing in a colonoscopy-based surveillance program (CSP) leads to earlier diagnosis. J Gastroen Hepatol 2008;23:A203.
21. Wong MC, Tsoi KK, Ng SS, Lou VW, Choi SY, Ling KW, et al. A comparison of the acceptance of immunochemical faecal occult blood test and colonoscopy in colorectal cancer screening: a prospective study among Chinese. Aliment Pharm Ther 2010;32:74-82.
22. Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas A, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 2012;366:697-706.
23. Michie S, McDonald V, Marteau T. Understanding responses to predictive genetic testing: A grounded theory approach. Psychol Health 1996;11:455-70.
24. Miles A, Atkin WS, Kralj-Hans I, Wardle J. The psychological impact of being offered surveillance colonoscopy following attendance at colorectal screening using flexible sigmoidoscopy. J Med Screen 2009;16:124-30.
25. Liljegren A, Lindgren G, Brandberg Y, Rotstein S, Nilsson B, Hatschek T, et al. Individuals with an increased risk of colorectal cancer: Perceived benefits and psychological aspects of surveillance by means of regular coloscopies. J Clin Oncol 2004;22:1736-42.
26. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375:1624-33.
27. von Wagner C, Halligan S, Atkin WS, Lilford RJ, Morton D, Wardle J. Choosing between CT colonography and colonoscopy in the diagnostic context: a qualitative study of influences on patient preferences. Health Expect 2009;12:18-26.
28. Ghanouni A, Smith SG, Halligan S, Plumb A, Boone D, Magee MS, et al. Public perceptions and preferences for CT colonography or colonoscopy in colorectal cancer screening. Patient Educ Couns 2012;89:116-21.
29. NHS Cancer Screening Programmes. Bowel Cancer Screening: The Colonoscopy Investigation http://www.cancerscreening.nhs.uk/bowel/publications/colonoscopyinvestigation-large-print.pdf (accessed 25 Apr 2013).
30. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77-101.
31. QSR International. NVivo (Version 9) [Software]. QSR International Pty Ltd. Available from: http://www.qsrinternational.com/default.aspx. 2010.
32. Department for Communities and Local Government. The English indicies of deprivation 2010. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/6320/1870718.pdf (accessed 25 Apr 2013).
33. Office for National Statistics. 2011 census, key statistics for local authorities in England and Wales. http://www.ons.gov.uk/ons/rel/census/2011-census/key-statistics-for-localauthorities-in-england-and-wales/index.html (accessed 25 Apr 2013).